Access cutting-edge lung transplant treatment through this clinical trial at a research site in Baltimore. Study-provided care at no cost to qualified participants.
Access lung transplant specialists in Baltimore at no cost
This study follows strict safety protocols and ethical guidelines
All study-related lung transplant treatment provided free
The purpose of this study is to see if taking the study drug, Belumosudil, for 52 weeks in addition to your usual care and medication, will prevent Chronic Lung Allograft Dysfunction (CLAD) in participants who have a lung biopsy that shows evidence of rejection or inflammation to the transplanted lung(s). For this study, biopsies that show evidence of Acute Rejection (AR), Lymphocytic Bronchiolitis (LB), Organizing Pneumonia (OP) or Acute Lung Injury (ALI) are referred to as "Qualifying Biopsies
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Check if you qualify for this lung transplant clinical trial in Baltimore, MD
If you're searching for lung transplant treatment options in Baltimore, MD, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Baltimore research site is actively enrolling participants for this clinical trial. You'll receive care from experienced lung transplant specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.